# Monoamine Oxidase B (MAO-B)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/monoamine-oxidase-b-mao-b
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-18
**Evidence Score:** 8 / 10
**Category:** Enzyme
**Also Known As:** MAO-B, Monoamine oxidase type B, MAO B, Monoamine:oxygen oxidoreductase (deaminating) (flavin-containing) B, Tyramine oxidase B, Phenylethylamine oxidase, MAOB enzyme

## Overview

Monoamine Oxidase B (MAO-B) is a [mitochondrial](/ingredients/condition/energy) enzyme that metabolizes [dopamine](/ingredients/condition/mood), phenylethylamine, and other monoamines in the brain. This enzyme plays a crucial role in neurotransmitter regulation, [cognitive function](/ingredients/condition/cognitive), and neuroprotection through its control of dopaminergic signaling pathways.

## Health Benefits

- Supports [cognitive function](/ingredients/condition/cognitive) and memory by breaking down dopamine, a neurotransmitter essential for focus and recall. - Regulates mood and emotional well-being by modulating dopamine and phenylethylamine levels, reducing risk of mood disorders. - Influences neuroprotection, as MAO-B inhibition has been shown to slow neurodegeneration by up to 40% in Parkinson’s studies. - Enhances alertness and motivation by optimizing dopamine availability in the brain. - May reduce [oxidative stress](/ingredients/condition/antioxidant) by limiting the formation of neurotoxic byproducts during neurotransmitter breakdown. - Supports healthy aging by preserving cognitive function and mental agility. - Aids in managing symptoms of neurodegenerative diseases by maintaining neurotransmitter balance. - Promotes [emotional resilience](/ingredients/condition/mood) by stabilizing mood-related biochemicals.

## Mechanism of Action

MAO-B catalyzes the oxidative deamination of [dopamine](/ingredients/condition/mood), phenylethylamine, and benzylamine using FAD as a cofactor, producing aldehydes, ammonia, and hydrogen peroxide. The enzyme is primarily located in astrocytes and increases with age, leading to enhanced dopamine [metabolism](/ingredients/condition/weight-management). MAO-B inhibition preserves dopamine levels in the synaptic cleft, enhancing dopaminergic neurotransmission and potentially protecting against neurodegeneration.

## Clinical Summary

Clinical studies on MAO-B inhibitors like selegiline and rasagiline demonstrate [neuroprotective effect](/ingredients/condition/cognitive)s in Parkinson's disease patients, with trials showing 20-30% reduction in disease progression markers. A 5-year study of 800 early Parkinson's patients found MAO-B inhibitor treatment delayed need for levodopa therapy by 9 months. Research indicates MAO-B activity increases 4-6 fold with aging, correlating with cognitive decline. However, most evidence focuses on pharmaceutical MAO-B inhibitors rather than natural enzyme modulation, limiting conclusions about supplemental approaches.

## Nutritional Profile

- Flavin-containing enzyme.
- Breaks down monoamine [neurotransmitter](/ingredients/condition/cognitive)s.
- Involved in [dopamine](/ingredients/condition/mood) [metabolism](/ingredients/condition/weight-management).

## Dosage & Preparation

No direct supplementation; modulation through diet and lifestyle choices. Consult a healthcare provider before use.

## Safety & Drug Interactions

MAO-B inhibitors can cause serious interactions with tyramine-rich foods, leading to hypertensive crises, though this risk is lower than with MAO-A inhibitors. Common side effects include [insomnia](/ingredients/condition/sleep), dizziness, and nausea, occurring in 10-15% of users. Contraindications include concurrent use with meperidine, tramadol, and certain antidepressants due to [serotonin](/ingredients/condition/mood) syndrome risk. Pregnant and breastfeeding women should avoid MAO-B modulators due to insufficient safety data and potential effects on fetal [neurotransmitter](/ingredients/condition/cognitive) development.

## Scientific Research

Human trials and observational studies have explored its role in neurodegenerative diseases and mood disorders.

## Historical & Cultural Context

Identified in the 20th century, MAO-B has been studied for its role in neurological health and aging.

## Synergistic Combinations

L-Dopa, Ginkgo Biloba, Coenzyme Q10

## Frequently Asked Questions

### Does MAO-B inhibition help with Parkinson's disease symptoms?

Yes, MAO-B inhibition is a well-established therapeutic strategy in Parkinson's disease. By blocking MAO-B, dopamine degradation in the striatum slows significantly, preserving dopaminergic neurotransmission in areas most affected by the disease. Clinical studies have shown that MAO-B inhibition can slow neurodegeneration by up to 40% and reduce motor symptom progression. Pharmaceutical MAO-B inhibitors like selegiline and rasagiline are approved treatments, while certain natural compounds may offer milder inhibitory effects. Always consult a neurologist before modifying any Parkinson's treatment protocol.

### How does MAO-B affect dopamine levels in the brain?

MAO-B directly controls dopamine availability by catalyzing its oxidative deamination in a reaction that uses FAD as a cofactor. This process converts dopamine into its aldehyde metabolite, ammonia, and hydrogen peroxide. When MAO-B activity is high — as occurs with aging or stress — dopamine is broken down more rapidly, reducing levels in the synaptic cleft. Inhibiting or modulating MAO-B activity preserves dopamine concentrations, supporting focus, motivation, mood stability, and cognitive performance. This mechanism underpins both pharmaceutical and nutraceutical approaches to dopamine optimization.

### Can high MAO-B activity contribute to depression or low mood?

Elevated MAO-B activity can lower phenylethylamine and dopamine levels, both of which are closely linked to mood regulation and emotional well-being. Research indicates that excessive MAO-B-driven metabolism of these monoamines is associated with increased vulnerability to mood disorders, including depression. Brain imaging studies have shown higher MAO-B density in individuals with major depressive disorder. Modulating MAO-B activity through diet, lifestyle, or targeted nutraceuticals may help stabilize mood-related neurochemistry, though clinical depression should always be evaluated and managed by a qualified healthcare professional.

### What role does MAO-B play in cognitive decline and memory loss?

MAO-B activity increases significantly with age and is concentrated in astrocytes throughout the brain. This age-related rise accelerates dopamine breakdown, impairing dopaminergic signaling pathways critical for working memory, attention, and executive function. Elevated MAO-B also generates hydrogen peroxide as a byproduct, contributing to oxidative stress and neuronal damage over time. Suppressing excessive MAO-B activity has been investigated as a strategy to preserve cognitive function in aging populations, with some studies suggesting benefits for mental agility, recall speed, and overall neurological health in older adults.

### Is there a connection between MAO-B and oxidative stress in the brain?

Yes, MAO-B-mediated neurotransmitter metabolism generates hydrogen peroxide as a direct byproduct of the oxidative deamination reaction. In brain regions with high MAO-B density, such as the basal ganglia and cortex, excessive hydrogen peroxide production can overwhelm antioxidant defenses, causing oxidative damage to mitochondria, lipids, and DNA. This mechanism is particularly relevant in aging and neurodegeneration. Limiting excessive MAO-B activity may therefore reduce oxidative burden in neural tissue, offering a neuroprotective benefit that complements antioxidant supplementation strategies.

### How does MAO-B relate to phenylethylamine and mood elevation?

Phenylethylamine (PEA) is a trace amine synthesized in the brain that produces feelings of alertness, euphoria, and emotional well-being. MAO-B is the primary enzyme responsible for PEA degradation, and it does so extremely rapidly — PEA's half-life in the brain is only minutes under normal MAO-B activity. When MAO-B is inhibited, PEA accumulates and exerts stronger stimulatory and mood-enhancing effects. This relationship explains why MAO-B inhibition is associated with improved emotional resilience and motivation, and why PEA-containing supplements are most effective when paired with MAO-B modulation.

### Can lifestyle changes reduce excess MAO-B activity naturally?

Emerging evidence suggests that certain lifestyle factors can influence MAO-B activity without pharmaceutical intervention. Regular aerobic exercise has been associated with improved dopaminergic tone and may attenuate age-related MAO-B upregulation. Diets rich in polyphenols — found in berries, green tea, and dark chocolate — contain compounds with documented MAO-B inhibitory properties in preclinical studies. Stress reduction practices may also help, as chronic stress alters monoamine metabolism. While these approaches are unlikely to replicate pharmaceutical inhibitor potency, they may support healthier MAO-B activity levels as part of a broader neuroprotective lifestyle strategy.

### What are the risks of excessive MAO-B inhibition?

While modulating MAO-B activity offers neuroprotective and mood-enhancing potential, excessive inhibition carries meaningful risks. Because MAO-B and MAO-A share some substrate overlap at high inhibitor doses, potent or non-selective inhibition can provoke the tyramine pressor effect — a dangerous hypertensive reaction triggered by tyramine-rich foods such as aged cheeses, cured meats, and fermented beverages. Additionally, over-accumulation of dopamine and phenylethylamine may cause agitation, insomnia, or cardiovascular stress. Interactions with serotonergic medications can also trigger serotonin syndrome. Any intentional MAO-B modulation should be supervised by a qualified healthcare provider.

### What is the difference between MAO-A and MAO-B enzymes?

MAO-A primarily metabolizes serotonin, norepinephrine, and epinephrine, while MAO-B specifically targets dopamine, phenylethylamine, and benzylamine. MAO-A is found in neurons and peripheral tissues, whereas MAO-B is predominantly located in astrocytes and increases significantly with aging.

### How does MAO-B activity change with age?

MAO-B activity increases 4-6 fold between ages 20-80, leading to enhanced dopamine breakdown and potentially contributing to age-related cognitive decline. This age-related increase occurs primarily in glial cells and may explain why dopaminergic function deteriorates with aging.

### Can natural compounds inhibit MAO-B enzyme?

Yes, natural compounds like curcumin, resveratrol, and green tea catechins show MAO-B inhibitory activity in laboratory studies. However, their potency is significantly lower than pharmaceutical inhibitors like selegiline, and clinical effectiveness for neuroprotection remains unproven.

### What foods should be avoided with MAO-B inhibitors?

High-tyramine foods like aged cheeses, cured meats, fermented products, and red wine should be limited but are less problematic with MAO-B inhibitors than MAO-A inhibitors. The tyramine restriction is generally milder, but monitoring blood pressure is still recommended when consuming these foods.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*